StayCurrentMD · Childhood Cancer Genomics PDQ®
Follow
Guideline1 min read·Published Mar 2020Older

Childhood Cancer Genomics PDQ®

Guideline · Mar 2020 · 1 min read

In brief

In brief

NCI's evidence-based clinical reference on genomic approaches to childhood cancer diagnosis and treatment. Covers molecular profiling techniques, genetic testing strategies, and precision medicine applications for pediatric malignancies.

  • PDQ® provides evidence-based genomic information for childhood cancers, updated regularly by NCI expert panels.
  • Genomic profiling increasingly guides risk stratification and targeted therapy selection in pediatric oncology.
  • Germline testing identifies hereditary cancer predisposition syndromes, informing family counseling and surveillance.

Written by the GCMD Library team from the guideline.

National Institute of Health and National Cancer Institute Childhood Cancer Genomics (PDQ®)–Health Professional Version

Read it at the source ↗

This guideline lives on cancer.gov.

Open it on cancer.gov ↗
Try
Intelligent Search· scoped to this guideline · not medical adviceSearch the whole library →